Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, Inoue A, Okamoto I, Kiura K, Kawaguchi T, Yamamoto N, Miyaoka E, Yoshino I, Date H. Shukuya T, et al. Among authors: shintani y. J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1274-1285. doi: 10.1002/jcsm.13216. Epub 2023 Mar 10. J Cachexia Sarcopenia Muscle. 2023. PMID: 36905129 Free PMC article.
Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, Fujii Y, Mitsudomi T, Yoshimura M, Maniwa T, Suzuki K, Kataoka K, Sugiyama Y, Kondo T, Date H; Japanese Association for Chest Surgery. Sato T, et al. J Thorac Cardiovasc Surg. 2014 May;147(5):1604-1611.e3. doi: 10.1016/j.jtcvs.2013.09.050. Epub 2013 Nov 20. J Thorac Cardiovasc Surg. 2014. PMID: 24267779 Free article.
What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Miyajima M, Watanabe A, Sato T, Teramukai S, Ebina M, Kishi K, Sugiyama Y, Kondo H, Kobayashi S, Takahashi Y, Ito H, Yamamoto R, Sawada S, Fujimori H, Okabe K, Arikura J, Shintani Y, Nakamura H, Toyooka S, Hasumi T, Watanabe T, Hata Y, Iwata H, Aoki M, Funai K, Inoue S, Kawashima O, Iida T, Date H. Miyajima M, et al. Among authors: shintani y. Surg Today. 2018 Apr;48(4):404-415. doi: 10.1007/s00595-017-1605-8. Epub 2017 Nov 9. Surg Today. 2018. PMID: 29124429
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Okami J, et al. Among authors: shintani y. J Thorac Oncol. 2019 Feb;14(2):212-222. doi: 10.1016/j.jtho.2018.10.002. Epub 2018 Oct 10. J Thorac Oncol. 2019. PMID: 30316011 Free article.
Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry.
Igawa S, Naoki K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I. Igawa S, et al. Among authors: shintani y. Lung Cancer. 2020 Aug;146:160-164. doi: 10.1016/j.lungcan.2020.05.038. Epub 2020 Jun 6. Lung Cancer. 2020. PMID: 32540559
Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database.
Kobayashi K, Soejima K, Fukunaga K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I; Group on behalf of the Japanese Joint Committee of Lung Cancer Registry. Kobayashi K, et al. Among authors: shintani y. Lung Cancer. 2020 Aug;146:236-243. doi: 10.1016/j.lungcan.2020.06.015. Epub 2020 Jun 18. Lung Cancer. 2020. PMID: 32590236
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases.
Suda K, Mitsudomi T, Shintani Y, Okami J, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Miyaoka E, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Suda K, et al. Among authors: shintani y. Ann Thorac Surg. 2021 Jan;111(1):269-276. doi: 10.1016/j.athoracsur.2020.05.041. Epub 2020 Jun 29. Ann Thorac Surg. 2021. PMID: 32615091
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study.
Fukumoto K, Mori S, Shintani Y, Okami J, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Miyaoka E, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Fukumoto K, et al. Among authors: shintani y. Lung Cancer. 2020 Nov;149:120-129. doi: 10.1016/j.lungcan.2020.09.011. Epub 2020 Sep 19. Lung Cancer. 2020. PMID: 33010640
792 results